Anemia in older men stems from three broad categories that account for roughly equal shares of cases: nutritional deficiencies (especially iron and vitamin B12), chronic disease (kidney disease, inflammation, and bone marrow disorders), and a surprisingly large group where no clear cause is ever found. About 11% of men aged 65 and older in the United States are anemic, and that figure climbs steeply past age 85. The causes overlap more than most people expect, and identifying the right one matters because treatment for one type can be useless or even harmful for another.
How Common Anemia Is in Older Men
Anemia gets more common with every decade of life, but the pattern in men is distinct. In women, anemia rates peak twice: once during reproductive years and again in very old age. In men, the curve simply rises with each passing decade, with no plateau or dip along the way.1PLoS ONE. The Prevalence of Anemia and Moderate-Severe Anemia in the US Population (NHANES 2003-2012) By age 85 and older, more than one in five people are anemic.2PubMed. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia
The threshold used to define anemia in men is a hemoglobin level below 130 g/L (13 g/dL), set by the World Health Organization based originally on younger populations. Some clinicians have questioned whether that cutoff is too strict for elderly men, but research in people aged 85 and older confirmed that hemoglobin below that line still predicts higher mortality, so age-adjusted thresholds have not replaced the standard definition.3JAMA. The Definition of Anemia in Older Persons Most anemia in older adults is mild, with only about 1.6% of men falling below 110 g/L.2PubMed. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia That mildness is deceptive, though, because even modest drops in hemoglobin carry real health consequences in this age group.
Iron Deficiency and Gastrointestinal Blood Loss
Iron deficiency is the single most treatable cause of anemia in older men, and in this population it almost always points to blood loss somewhere in the digestive tract. Unlike younger women, who commonly lose iron through menstruation, older men who are low on iron are losing it internally. Chronic, often invisible bleeding from ulcers, erosions, polyps, or tumors is the usual culprit. Among patients with gastrointestinal bleeding, the rate of iron-deficiency anemia has been estimated at around 61%.4PubMed Central. Diagnosis and treatment of iron-deficiency anemia in gastrointestinal bleeding: A systematic review
The clinical concern is what the bleeding represents. In a study of elderly patients with iron-deficiency anemia who underwent endoscopy, upper-GI lesions were found in over half of cases, and colon lesions in about a quarter. Roughly one in six of those patients turned out to have a gastrointestinal cancer, including cancers of the colon, stomach, and esophagus.5PubMed. Iron deficiency anemia in the elderly: prevalence and endoscopic evaluation of the gastrointestinal tract in outpatients That is why guidelines strongly recommend investigating the GI tract before simply prescribing iron supplements to an older man with low iron. The anemia may be the first visible sign of something serious that is otherwise painless and easy to miss.
Chronic Kidney Disease and Declining Erythropoietin
Kidney function declines with age, and the kidneys are responsible for producing erythropoietin (EPO), the hormone that tells bone marrow to make red blood cells. As kidney filtration drops, EPO production falls with it. In older adults with significantly reduced kidney function, EPO levels are measurably lower than in those with healthy kidneys, even after accounting for age and hemoglobin.6Archives of Internal Medicine. Renal Function, Erythropoietin, and Anemia of Older Persons: The InCHIANTI Study The result is a gradual reduction in red blood cell production that can go unnoticed for years.
What makes this trickier is that EPO production appears to be blunted in some older men even when their kidneys look reasonably healthy on standard tests. Research on elderly patients with anemia that had no other identifiable cause found that their EPO response was inadequate even after accounting for hemoglobin level and kidney function, suggesting the signaling pathway itself becomes less effective with age.7Blood. Erythropoietin in Elderly Patients with Anemia of Unknown Etiology This blunted EPO response is one of the reasons so many cases of anemia in elderly men end up classified as “unexplained.”
Vitamin B12 Deficiency and Malabsorption
Vitamin B12 deficiency is a common and underappreciated contributor to anemia in older adults. The issue is usually not that older men eat too little B12, but that they can no longer absorb it properly. A condition called food-cobalamin malabsorption syndrome, typically caused by the gradual thinning of the stomach lining (atrophic gastritis), prevents the body from freeing B12 from food proteins so it can be absorbed in the intestine. Helicobacter pylori infection, which is more common in older adults, accelerates that gastric thinning.8PubMed Central. Cobalamin deficiency in elderly patients: a personal view
Medications compound the problem. Proton pump inhibitors (PPIs), which millions of older adults take for acid reflux, reduce gastric acid secretion and further impair B12 release from food. Metformin, widely prescribed for type 2 diabetes, also interferes with B12 absorption through a different pathway.9Journal of Pharmacy Practice and Research. Vitamin B12 deficiency in older people: a practical approach to recognition and management The resulting anemia is megaloblastic, meaning red blood cells are larger than normal, and it can be accompanied by neurological symptoms like numbness, tingling, and difficulty with balance. Those neurological effects can progress even if the anemia itself remains mild, so catching B12 deficiency early matters beyond just correcting hemoglobin levels.
Chronic Inflammation and the Hepcidin Problem
Older adults commonly carry a low level of chronic inflammation driven by conditions like heart disease, diabetes, autoimmune disorders, or chronic infections. This background inflammation triggers the liver to produce a hormone called hepcidin, which acts as a gatekeeper for iron. When hepcidin is high, iron gets locked inside cells and cannot enter the bloodstream to be used for making red blood cells. The body may actually have plenty of stored iron, but it is functionally unavailable.
In a study of people aged 85 and older, those with anemia of inflammation had significantly elevated hepcidin levels compared to non-anemic individuals. The same pattern appeared in participants with kidney-related anemia and, interestingly, even in those whose anemia had no identified cause.10Haematologica. Plasma hepcidin levels and anemia in old age. The Leiden 85-Plus Study This overlap is part of what makes diagnosis so challenging: inflammation, kidney disease, and “unexplained” anemia share a hormonal fingerprint, even though they are technically considered different conditions. It also means that giving iron supplements to someone with inflammation-driven anemia is often ineffective, because the iron gets absorbed but then trapped by hepcidin before it reaches the bone marrow.
The Role of Declining Testosterone
Testosterone stimulates red blood cell production, and levels decline naturally as men age. This link between testosterone and hemoglobin is well established: it is the reason men generally have higher hemoglobin than women throughout adult life, and why anabolic steroid abuse can cause dangerously high red blood cell counts. In older men, the reverse becomes relevant. A study of community-dwelling older adults found that men in the lowest quartile of total testosterone were roughly five times more likely to be anemic than those in the highest quartile. When bioavailable testosterone (the fraction that is not bound to proteins and can actively reach tissues) was measured instead, the odds were even more striking.11PubMed Central. Low Testosterone Levels and the Risk of Anemia in Older Men and Women
Among men who were not yet anemic at the start of that study, those with low total testosterone had about twice the risk of developing anemia over the following three years, while those with low bioavailable testosterone had nearly four times the risk.11PubMed Central. Low Testosterone Levels and the Risk of Anemia in Older Men and Women This does not mean that testosterone replacement is a blanket fix for anemia in older men. The hormone carries its own risks, including thickening the blood too much in the opposite direction. But it does mean that testosterone status deserves a look when anemia has no other obvious explanation, particularly in men who also have symptoms of low testosterone such as fatigue and reduced muscle mass.
Medications That Cause or Worsen Anemia
Older men take more medications than almost any other demographic, and several commonly prescribed drugs can contribute to anemia through different mechanisms. PPIs, already mentioned for their role in B12 malabsorption, can also cause iron-deficiency anemia on their own. A case report documented iron-deficiency anemia developing after 25 years of PPI use, with the reduced gastric acid impairing the body’s ability to absorb dietary iron from the gut.12PubMed Central. Iron Deficiency Anemia Due to the Long-term Use of a Proton Pump Inhibitor While that is an extreme duration, millions of older adults take PPIs for years without periodic reassessment.
Androgen deprivation therapy (ADT), used to treat prostate cancer by suppressing testosterone, is a particularly potent cause of anemia in older men. Since androgens directly stimulate the bone marrow to produce red blood cells, removing them predictably reduces blood cell counts. Men on ADT experience significant drops in hemoglobin, and current ADT use has been associated with a nearly threefold increased rate of anemia compared to nonuse.13PubMed. Androgen Deprivation Therapy and the Risk of Anemia in Men with Prostate Cancer Research has shown this reflects reduced proliferation of red blood cell precursors in the marrow itself, resulting in lower red cell counts, lower hemoglobin, and lower hematocrit.14PubMed Central. Mechanisms responsible for reduced erythropoiesis during androgen deprivation therapy in men with prostate cancer For men on ADT who develop mild anemia with normal-looking red blood cells, clinicians familiar with this effect can often avoid unnecessary invasive workups.15PubMed Central. Hematological changes during androgen deprivation therapy
Bone Marrow Disorders and Myelodysplastic Syndromes
The bone marrow itself can be the source of the problem. Myelodysplastic syndromes (MDS) are a group of disorders in which the marrow produces blood cells that are defective or die before they mature. The refractory anemia subtype of MDS is a common and often incidental finding in hospitalized elderly patients, where it frequently causes anemia and other blood count abnormalities.16PubMed. Prevalence and survival of myelodysplastic syndrome of the refractory anemia type in hospitalized cognitively different geriatric patients MDS sometimes progresses to acute leukemia, but in many older adults the condition remains stable and is managed conservatively with transfusions or supportive care rather than aggressive treatment.
The boundary between MDS and unexplained anemia is blurrier than it might seem. Some fraction of cases initially labeled as unexplained anemia eventually turn out to involve clonal abnormalities in blood stem cells that are essentially early-stage or low-grade marrow disorders.17PubMed Central. Unexplained Anemia in the Elderly As genetic testing of bone marrow becomes more refined, the share of truly “unexplained” cases may shrink.
The Roughly One Third That Remains Unexplained
Even after a thorough workup, about 30% of anemia cases in older adults have no identifiable cause.17PubMed Central. Unexplained Anemia in the Elderly This is not a casual diagnostic shrug: it reflects a real category of mild, persistent anemia that does not fit neatly into iron deficiency, kidney disease, B12 deficiency, inflammation, or marrow failure. Researchers have proposed that this “unexplained anemia” likely results from a combination of subtle, overlapping age-related changes: slightly reduced EPO signaling, mildly elevated hepcidin from low-grade inflammation, early clonal changes in marrow stem cells, and declining testosterone. None of these individually crosses a diagnostic threshold, but together they nudge hemoglobin below the line.
The elevated hepcidin levels found in patients with unexplained anemia support this idea. As noted earlier, participants with no identifiable cause of anemia still had significantly higher hepcidin than those without anemia.10Haematologica. Plasma hepcidin levels and anemia in old age. The Leiden 85-Plus Study Combined with the blunted EPO response seen in the same population,7Blood. Erythropoietin in Elderly Patients with Anemia of Unknown Etiology the picture suggests that aging itself gradually compromises the body’s ability to maintain red blood cell production at younger levels. Whether this represents a distinct disease process or simply the tail end of normal aging is one of the open questions in geriatric hematology.
Why Even Mild Anemia Matters in Older Men
It is tempting to dismiss mild anemia as an inevitable part of getting older, but the health consequences are real and measurable. In a large study of older men, every 10 g/L drop in hemoglobin was associated with a 20% increase in the risk of death from any cause and a 13% increase in major cardiovascular events including heart attacks and heart failure.18Canadian Journal of Cardiology. Hemoglobin, Frailty, and Major Adverse Cardiovascular Events in Older Men Whether anemia directly causes these outcomes or acts as a marker for underlying illness (or both) remains debated, but the association is strong enough to warrant attention.
Beyond cardiac risk, anemia is tied to frailty and functional decline. Community-dwelling older adults with anemia had more than twice the odds of being frail and had significantly weaker grip strength compared to their non-anemic peers. They also took longer to complete a timed walking test, reflecting poorer physical performance in daily activities.19PubMed. Prevalence of Anemia and Its Association with Frailty, Physical Function and Cognition in Community-Dwelling Older Adults: Findings from the HOPE Study For an older man trying to maintain independence, that decline in strength and mobility may matter more than any lab number.
Diagnostic Pitfalls in Older Men
Standard blood tests can miss iron-deficiency anemia in older adults because the usual marker, ferritin, is unreliable in this population. Ferritin rises in response to inflammation, and since chronic low-grade inflammation is common in older adults, ferritin levels can look normal or even high while the body’s functional iron supply is actually depleted. In a study comparing standard lab tests to bone marrow biopsy (the gold standard for confirming iron deficiency), routine tests correctly identified iron-deficiency anemia in only 16% of confirmed cases. A calculated index combining transferrin receptor and ferritin values boosted that sensitivity to 88%, catching the majority of cases that standard labs missed.20JAMA Internal Medicine. Diagnosis of Iron Deficiency Anemia in the Elderly by Transferrin Receptor–Ferritin Index
The practical takeaway is that a ferritin level reported as “normal” in an older man does not necessarily rule out iron deficiency. If symptoms and the clinical picture suggest it, more sensitive testing or direct assessment of iron stores may be needed. This is especially important because iron deficiency in this group demands a search for the bleeding source, while other forms of anemia do not. Getting the diagnosis wrong in either direction is costly: missing iron deficiency means missing a potentially dangerous GI lesion, while giving iron to someone with inflammation-driven anemia means adding free iron to a system that may already have trouble handling it safely.21PubMed Central. Iron status in the elderly
Racial Differences in Anemia Risk and Thresholds
Anemia rates differ substantially across racial groups, and the standard diagnostic cutoffs may not serve all populations equally. Anemia is more common in older Black adults than in older white adults, but what that anemia means for health outcomes is not the same. In a community-based study of older adults, white men with hemoglobin values even modestly below the WHO threshold faced elevated mortality risk. Black men, by contrast, showed elevated mortality only when hemoglobin dropped more than 20 g/L below the cutoff, a much more severe deficit. Black men classified as anemic by the standard WHO criteria were not at increased risk for death or mobility disability, suggesting that the current threshold may overcall anemia in this population.22PubMed Central. Racial variation in the relationship of anemia with mortality and mobility disability among older adults
The reasons for this difference are not fully settled. Part of the gap likely reflects population-level differences in normal hemoglobin distribution, partly influenced by the high prevalence of alpha-thalassemia trait in people of African descent, which lowers hemoglobin without causing illness. Whatever the explanation, applying a single universal cutoff to all older men likely leads to overdiagnosis in some groups and underdiagnosis in others. For an individual patient, a hemoglobin value right at the threshold means more in context than in isolation.
The Emerging Gut Microbiome Connection
A newer area of research links the composition of gut bacteria to iron status and anemia risk. The relationship appears to run in both directions: iron deficiency can alter which microbes thrive in the gut, and the gut microbiome in turn affects how efficiently iron is absorbed and used. People with iron-deficiency anemia tend to have less diverse gut bacteria, with fewer of the species that produce short-chain fatty acids (which help maintain a healthy intestinal lining) and more of the species that compete aggressively for iron.23PubMed Central. Gut microbiota and iron deficiency anemia: Mechanisms, microbial signatures, and dietary interactions (A narrative review) Direct proof that correcting gut bacteria improves anemia in humans is still limited, but the findings are shaping how researchers think about iron absorption in aging populations, particularly given that older adults already have reduced gastric acid and altered gut environments that may compound these microbial shifts.